Accendra Health, Inc.

NYSE:ACH

Medical - Distribution

Healthcare
$0.71 +3.64%

+$0.12 today

Market cap
$54.22M
Beta
1.63
P/E (TTM)
-0.2
EPS (TTM)
-$14.11
52W Low $1.84High $9.55

Volume 1.41M

Average 0.83M

ACH Interest Expense

Cost of servicing the company's debt during the period.

Accendra Health, Inc.NYSE: ACH

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense declines year over year

Q1 FY2026 interest expense of $32.87M fell 3.2% year over year, ahead of the -3.8% change in trailing-twelve-month interest expense. Sequentially, it rose 14.6% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.

Context

  • Interest expense amounted to 4.7% of revenue in FY2025, up 3.3 pp from a year earlier.
  • Interest expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -3.2% holds above the trailing-twelve-month pace of -3.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$32.87M+14.6% QoQ
Last fiscal yearDec 2025
$129.2M-10.2% YoY
LTMMar 2026
$136.75M-3.8% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.2%——
1 year-10.2%——
3-year CAGR+0.1%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
129.2M USD
Year-over-year change
-10.2%
4-year CAGR
+28.0%

Interest Expense vs competitors

How ACH compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -3.8% is the 5th highest of 10, against a peer median of -44.7%.
  • Interest expense amounts to 5.0% of revenue for ACH, versus a peer median of 4.0%.
ACH Competitors
Interest Expense for ACH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACHAccendra Health, Inc.LTM Mar 2026$136.75M USD-3.8%+0.1%5.0%
CGCCanopy Growth CorporationLTM Mar 2026CA$40.92M CAD-45.1%-32.9%13.1%
HITIHigh Tide Inc.LTM Apr 2026CA$15.52M CAD+10.1%+10.4%2.3%
OMOutset Medical, Inc.LTM Mar 2026$7.02M USD-67.3%+57.6%6.0%
CVRXCVRx, Inc.LTM Mar 2026$5.92M USD+21.0%+228.1%10.0%
SGHTSight Sciences, Inc.LTM Mar 2026$2.61M USD-44.7%+4.8%3.3%
CABACabaletta Bio, Inc.LTM Mar 2026$2.35M USD+125.1%——
ALLOAllogene Therapeutics, Inc.LTM Mar 2026$1.23M USD+270.1%——
BIOABioAge Labs, Inc.LTM Mar 2026$481K USD-65.8%+42.5%4.7%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
EDITEditas Medicine, Inc.LTM Mar 2026-$1.14M USD-151.6%—3.0%
Peer median (excluding ACH) —-44.7%+26.4%4.0%

Competitors are the stored peer set for ACH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.79B9.96B10.33B10.7B2.76B
Cost of Revenue8.27B8.13B8.21B8.48B1.56B
Gross Profit1.51B1.83B2.13B2.22B1.2B
Gross Margin15.5%18.3%20.6%20.7%43.5%
Research & Development12.1M0000
Selling, General & Admin1.08B1.55B1.81B1.91B1.05B
Operating Expenses1.14B1.68B2.02B2.43B1.05B
Depreciation & Amortization90.62M228.67M287.38M264.78M214.52M
EBITDA415.47M368.45M390.57M51.22M364.68M
EBITDA Margin4.2%3.7%3.8%0.5%13.2%
Operating Income368.47M142.91M104.51M(207.77M)150.16M
Operating Margin3.8%1.4%1.0%-1.9%5.4%
Interest Income00000
Interest Expense48.09M128.89M157.92M143.8M129.2M
Other Income / Expenses(91.72M)(132.02M)(159.23M)(149.59M)(252.11M)
Income Before Tax276.75M10.89M(54.73M)(357.36M)(101.95M)
Pre-Tax Margin2.8%0.1%-0.5%-3.3%-3.7%
Income Tax Expense55.17M(11.5M)(13.43M)5.33M729K
Net Income221.59M22.39M(41.3M)(362.69M)(1.1B)
Net Margin2.3%0.2%-0.4%-3.4%-39.8%
EPS (Basic)3.050.30(0.54)(4.73)(14.31)
EPS (Diluted)2.940.29(0.54)(4.73)(14.31)
Weighted Avg Shares72.74M74.5M75.79M76.74M76.9M
Weighted Avg Shares (Diluted)75.49M76.22M75.79M76.74M76.9M

Accendra Health, Inc.

NYSE:ACH

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.